A disassemblable microstrainer for biological specimens.

S. Christie,J. Edwardson

1968-03-01

Stain Technology

Abstract:

What problem does this paper attempt to address?

Differential Regulation of Integrin Alpha 5 and Beta 4 in Normal and Psoriatic Epidermal Keratinocytes

Jiong Zhou,Ji-Yang Shen,Xiao-Yong Man,Wei Li,Jia-Qi Chen,Sui-Qing Cai,Min Zheng

DOI: https://doi.org/10.1590/s2175-97902022e19685

2022-01-01

Brazilian Journal of Pharmaceutical Sciences

Abstract:Psoriasis is a chronic skin inflammation, characterized by impaired differentiation, hyperproliferation of keratinocytes involving pro-inflammatory factors interleukin (IL)-13/17A, tumor necrosis factor (TNE)-alpha, interferon (IFN)-gamma. Among the integrin family, alpha 5 is important for blood vessel formation, and beta 4 for proliferation, differentiation of keratinocytes. To investigate the expression and regulation of integrin alpha 5 and beta 4 in psoriatic keratinocytes. Skin biopsies were obtained from 14 psoriatic patients and 12 normal volunteers. We compared the immunolocalization and regulation of alpha 5 and beta 4 between the psoriatic and normal ones, before and after incubation with MEK/ERK pathway inhibitor U0126 by immunohistochemistry and western blot separately. Immunohistochemistry showed psoriatic keratinocytes had higher alpha 5 than normal ones. According to western blot, IL-17A and IL-13 increased normal keratinocytes' alpha 5 and beta 4 respectively, but psoriatic keratinocytes were the exact opposite. Incubated with U0126, normal keratinocytes' alpha 5 was enhanced by the 5 cytokines; while IL-13/17A, IFN-gamma suppressed beta 4. Psoriatic keratinocytes' alpha 5 was increased by IL-13/17A, decreased by IFN-gamma; but beta 4 increased by IL-17A, IFN-gamma. IL-13/17A, TNF-alpha, IFN-gamma regulate alpha 5 and beta 4 through ERK pathway whether normal or psoriasis. The normal and psoriatic keratinocytes respond to the
Analysis of Epithelial–mesenchymal Transition Markers in Psoriatic Epidermal Keratinocytes

Xiao-Yong Man,Xi-Bei Chen,Wei Li,Lilla Landeck,Ting-Ting Dou,Jia-Qi Chen,Jiong Zhou,Sui-Qing Cai,Min Zheng

DOI: https://doi.org/10.1098/rsob.150032

2015-01-01

Open Biology

Abstract:Psoriasis is similar to endpoints of epithelial–mesenchymal transition (EMT), a process of epithelial cells transformed into fibroblast-like cells. The molecular epithelial and mesenchymal markers were analysed in psoriatic keratinocytes. No obvious alteration of epithelial markers E-cadherin (E-cad), keratin 10 (K10), K14 and K16 was detected in psoriatic keratinocytes. However, significantly increased expression of Vim, FN, plasminogen activator inhibitor 1 (PAI-1) and Slug was seen. IL-17A and IL-13 at 50 ng ml−1 strongly decreased expression of K10, Vim and FN. TGF-β1 at 50 ng ml−1 promoted the production of N-cad, Vim, FN and PAI-1. Slug was decreased by dexamethasone (Dex), but E-cad was upregulated by Dex. Silencing of ERK partially increased E-cad and K16, but remarkably inhibited K14, FN, Vim, β-catenin, Slug and α5 integrin. Moreover, inhibition of Rho and GSK3 by their inhibitors Y27632 and SB216763, respectively, strongly raised E-cad, β-catenin and Slug. Dex decreased Y27632-mediated increase of β-catenin. Dex at 2.0 µM inhibited SB216763-regulated E-cad, β-catenin and slug. In conclusion, EMT in psoriatic keratinocytes may be defined as an intermediate phenotype of type 2 EMT. ERK, Rho and GSK3 play active roles in the process of EMT in psoriatic keratinocytes.
An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.

Miao Xu,Huiping Lu,Young-Hee Lee,Yelin Wu,Kewei Liu,Yuling Shi,Haoran An,Jingren Zhang,Xiaohu Wang,Yuping Lai,Chen Dong

DOI: https://doi.org/10.1016/j.immuni.2018.03.019

IF: 32.4

2018-01-01

Immunity

Abstract:Psoriasis is a chronic autoinflammatory skin disease. Although interleukin-17, derived from lymphocytes, has been shown to be critical in psoriasis, the initiation and maintenance of chronic skin inflammation has not been well understood. IL-25 (also called IL-17E), another IL-17 family cytokine, is well known to regulate allergic responses and type 2 immunity. Here we have shown that IL-25, also highly expressed in the lesional skin of psoriasis patients, was regulated by IL-17 in murine skin of a imiquimod (IMQ)-induced psoriasis model. IL-25 injection induced skin inflammation, whereas germline or keratinocyte-specific deletion of IL-25 caused resistance to IMQ-induced psoriasis. Via IL-17RB expression in keratinocytes, IL-25 stimulated the proliferation of keratinocytes and induced the production of inflammatory cytokines and chemokines, via activation of the STAT3 transcription factor. Thus, our data demonstrate that an IL-17-induced autoregulatory circuit in keratinocytes is mediated by IL-25 and suggest that this circuit could be targeted in the treatment of psoriasis patients.
IL-17C Amplifies Epithelial Inflammation in Human Psoriasis and Atopic Eczema

F. Lauffer,M. Jargosch,V Baghin,L. Krause,W. Kempf,M. Absmaier-Kijak,M. Morelli,S. Madonna,F. Marsais,L. Lepescheux,C. Albanesi,N. S. Mueller,F. J. Theis,C. Schmidt-Weber,S. Eyerich,T. Biedermann,N. Vandeghinste,S. Steidl,K. Eyerich

DOI: https://doi.org/10.1111/jdv.16126

2019-01-01

Journal of the European Academy of Dermatology and Venereology

Abstract:Background Key pathogenic events of psoriasis and atopic eczema (AE) are misguided immune reactions of the skin. IL-17C is an epithelial-derived cytokine, whose impact on skin inflammation is unclear. Objective We sought to characterize the role of IL-17C in human ISD. Methods IL-17C gene and protein expression was assessed by immunohistochemistry and transcriptome analysis. Primary human keratinocytes were stimulated and expression of cytokines chemokines was determined by qRT-PCR and luminex assay. Neutrophil migration towards supernatant of stimulated keratinocytes was assessed. IL-17C was depleted using a new IL-17C-specific antibody (MOR106) in murine models of psoriasis (IL-23 injection model) and AE (MC903 model) as well as in human skin biopsies of psoriasis and AE. Effects on cell influx (mouse models) and gene expression (human explant cultures) were determined. Results Expression of IL-17C mRNA and protein was elevated in various ISD. We demonstrate that IL-17C potentiates the expression of innate cytokines, antimicrobial peptides (IL-36G, S100A7 and HBD2) and chemokines (CXCL8, CXCL10, CCL5 and VEGF) and the autocrine induction of IL-17C in keratinocytes. Cell-free supernatant of keratinocytes stimulated with IL-17C was strongly chemotactic for neutrophils, thus demonstrating a critical role for IL-17C in immune cell recruitment. IL-17C depletion significantly reduced cell numbers of T cells, neutrophils and eosinophils in murine models of psoriasis and AE and led to a significant downregulation of inflammatory mediators in human skin biopsies of psoriasis and AE ex vivo. Conclusion IL-17C amplifies epithelial inflammation in Th2 and Th17 dominated skin inflammation and represents a promising target for the treatment of ISD.
Regulation of Involucrin in Psoriatic Epidermal Keratinocytes: The Roles of ERK1/2 and GSK-3β

Jia-Qi Chen,Xiao-Yong Man,Wei Li,Jiong Zhou,Lilla Landeck,Sui-Qing Cai,Min Zheng

DOI: https://doi.org/10.1007/s12013-012-9499-y

2013-01-01

Cell Biochemistry and Biophysics

Abstract:Psoriasis, a common inflammatory skin disease, is characterized by epidermal hyperplasia, abnormal differentiation, angiogenesis, immune activation, and inflammation. Involucrin is an early terminal differentiation marker of epidermal keratinocytes. In this study, we determined the immunolocalization of involucrin in psoriatic lesions and normal skin of individuals without psoriasis by means of immunofluorescence (IF) assay. Furthermore, the regulation of involucrin by interleukin (IL)-13, IL-17A, endothelin (ET)-1, tumor necrosis factor (TNF)- α , and interferon (IFN)- γ was investigated by Western blot. Extracellular regulate protein kinases 1/2 (ERK1/2) and glycogen syntheses kinase-3 β (GSK-3 β ) inhibitors were also included to define the roles of these signals in the production of involucrin in both psoriatic and normal keratinocytes. In psoriatic lesional skin, involucrin was detected in the stratum spinosum, but not in the basal or the cornified layer. In normal skin, involucrin was restricted to the granular layer and the upper stratum spinosum. IL-13, IL-17A, ET-1, TNF- α , and IFN- γ up-regulate expression of involucrin in both psoriatic and normal keratinocytes. However, this effect was abolished by ERK1/2 and GSK-3 β inhibitors. In conclusion, involucrin is up-regulated in psoriatic keratinocytes. IL-13, IL-17A, ET-1, TNF- α , and IFN- γ could increase involucrin protein levels in psoriatic and normal keratinocytes. The ERK1/2 and GSK-3 β signaling pathways may play positive roles in regulating epidermal differentiation as observed in psoriasis.
UBE2L3 Reduces TRIM21 Expression and IL-1β Secretion in Epidermal Keratinocytes and Improves Psoriasis-Like Skin

Xue-Yan Chen,Fan Xu,Jia-Qi Chen,Lilla Landeck,Si-Qi Chen,Yuan Zhou,Zhaoyuan Wang,Ni-Chang Fu,Min Zheng,Xuzhao Zhang,Xiao-Yong Man

DOI: https://doi.org/10.1016/j.jid.2022.10.016

2023-01-01

Abstract:Proinflammatory cytokines, such as IL-1β, are important mediators of psoriasis. UBE2L3, an E2 enzyme, is thought to be an indirect target of IL-1β secretion by binding to ubiquitin ligases such as TRIM21. However, its role in psoriasis remains unknown. In this study, we found that UBE2L3 expression was decreased in psoriatic epidermis, whereas caspase 1 and IL-1β signaling were strongly activated. When normal human epidermal keratinocytes were stimulated with nigericin, adenosine triphosphate, and poly(dA:dT), downregulation of UBE2L3 and increased secretion of IL-1β were observed. Treatment with a caspase 1 inhibitor reversed the decrease in the level of UBE2L3. In addition, UBE2L3 overexpression reduced TRIM21, decreased signal transducer and activator of transcription 3 pathway activity, and reduced the level of the IL-1β precursor (pro‒IL-1β). Consistently, silencing UBE2L3 enhanced TRIM21 expression, signal transducer and activator of transcription 3 activation, and pro‒IL-1β production. Finally, in an imiquimod-induced mouse model, UBE2L3 reduction and caspase 1 activation were localized in the epidermis, whereas overexpression of UBE2L3 ameliorated psoriasis-like lesions and reduced pro‒IL-1β and mature IL-1β levels in the epidermis. Thus, UBE2L3 may be a protective biomarker that regulates IL-1β and inhibits TRIM21 in the epidermis of psoriasis.
Epigenetic Regulation of IL-23 by E3 Ligase FBXW7 in Dendritic Cells is Critical for Psoriasis-like Inflammation.

Yinjing Song,Xiangtong Zhao,Hao Qu,Yixin Su,Rukun He,Luxia Chen,Lutong Fang,Jiaying Li,Ziqi Zou,Jia He,Zilong Li,Yaohan Xu,Xin Chen,Hao Cheng,Yong Xu,Qingqing Wang,Lihua Lai

DOI: https://doi.org/10.4049/jimmunol.2300023

2023-01-01

Abstract:Dendritic cells (DCs), a driver of psoriasis pathogenesis, produce IL-23 and trigger IL-23/IL-17 cytokine axis activation. However, the mechanisms regulating IL-23 induction remain unclear. In the current study, we found that mice with E3 ligase FBXW7 deficiency in DCs show reduced skin inflammation correlated with the reduction of IL-23/IL-17 axis cytokines in the imiquimod-induced psoriasis model. Fbxw7 deficiency results in decreased production of IL-23 in DCs. FBXW7 interacts with the lysine N-methyltransferase suppressor of variegation 39 homolog 2 (SUV39H2), which catalyzes the trimethylation of histone H3 Lys9 (H3K9) during transcription regulation. FBXW7 mediates the ubiquitination and degradation of SUV39H2, thus decreasing H3K9m3 deposition on the Il23a promoter. The Suv39h2 knockout mice displayed exacerbated skin inflammation with the IL-23/IL-17 axis overactivating in the psoriasis model. Taken together, our results indicate that FBXW7 increases IL-23 expression in DCs by degrading SUV39H2, thereby aggravating psoriasis-like inflammation. Inhibition of FBXW7 or the FBXW7/SUV39H2/IL-23 axis may represent a novel therapeutic approach to psoriasis.
Glycyrrhizin improves the pathogenesis of psoriasis partially through IL-17A and the SIRT1-STAT3 axis

Huang Qiong,Ling Han,Nanxue Zhang,Huyan Chen,Kexiang Yan,Zhenghua Zhang,Ying Ma,Jinhua Xu

DOI: https://doi.org/10.1186/s12865-021-00421-z

IF: 3

2021-05-27

BMC Immunology

Abstract:Abstract Background The anti-inflammatory effect of glycyrrhizin has been widely recognized, while the specific mechanism of glycyrrhizin in psoriasis remains poorly understood. Results In the imiquimod-induced mouse model of psoriasis (IMD), we found that glycyrrhizin can substantially improve the adverse symptoms in mice. The hematoxylin-eosin staining results showed that glycyrrhizin can also improve the pathological state of skin cells in IMD mice. Using enzyme-linked immunosorbent assay (ELISA), we found that glycyrrhizin substantially inhibited the expression of IL-17A and IFN-γ in the serum of IMD mice. In order to simulate the effect of IL-17A on keratinocytes in psoriasis, we treated HaCaT cells with 100 ng/mL IL-17A (IL-17A-HaCaT cells) for 48 h. Then, using cell-counting kit-8 (CCK-8) and ELISA assays, we found that glycyrrhizin inhibited the proliferation of IL-17A-HaCaT cells and reversed the promotion of IL-6, CCL20, and TNF-α induced by IL-17A. Further, western blotting (WB) results indicated that glycyrrhizin promoted the expression of SIRT1 and inhibited the expression of STAT3 and phosphorylated STAT3 (p-STAT3). By treating IL-17A-HaCaT cells with EX-527 (a potent and selective inhibitor of SIRT1), combined with CCK-8 and WB experiments, we initially found that EX-527 inhibited the proliferation of IL-17A-HaCaT cells and promoted the expression of STAT3, p-STAT3, and acetylated STAT3 (a-STAT3). However, when glycyrrhizin was added at the same time, the proliferation of IL-17A-HaCaT cells increased, and the expression of STAT3, p-STAT3, and a-STAT3 reduced. We then knocked down the expression of SIRT1 via small interfering RNA in IL-17A-HaCaT cells, and the results were consistent with those of EX-527. Conclusions Together, these results indicated that glycyrrhizin improved psoriasis by inhibiting the expression of IL-17A and IFN-γ in vivo and suppressed the proliferation of IL-17A-HaCaT cells and the expression of STAT3, p-STAT3, and a-STAT3 by upregulating SIRT1 in vitro.

immunology
Epidermal SIRT1 regulates inflammation, cell migration, and wound healing

Lei Qiang,Ashley Sample,Han Liu,Xiaoyang Wu,Yu-Ying He

DOI: https://doi.org/10.1038/s41598-017-14371-3

IF: 4.6

2017-10-26

Scientific Reports

Abstract:Sirtuins (SIRT1-7) are NAD-dependent proteins with the enzymatic activity of deacetylases and ADP ribosyltransferases. SIRT1 is the proto member of the proteins in the mammalian sirtuin family and plays multiple roles in aging and disease. Using mice with epidermis-specific SIRT1 deletion, we show that SIRT1 is required for efficient wound healing. SIRT1 deficiency in the epidermis inhibited the regeneration of both the epidermis and the dermal stroma. SIRT1 loss altered the production of many cytokines, inhibited the recruitment of macrophages, neutrophils, and mast cells, the recruitment and activation of fibroblasts, and angiogenesis in the granulation tissue. In keratinocytes, SIRT1 knockdown inhibited EMT, cell migration, and TGF-β signaling. For the first time, using skin-specific mouse model, we demonstrate that epidermal SIRT1 plays a crucial role in wound repair. These findings are novel in understanding how wound healing is regulated. Our findings provide in vivo and in vitro evidence that SIRT1 in the epidermis regulates cell migration, redox response, inflammation, epidermis re-epithelialization, granulation formation, and proper wound healing in mice.

multidisciplinary sciences
IL-6 Up-Regulates Expression of LIM-Domain Only Protein 4 in Psoriatic Keratinocytes through Activation of the MEK/ERK/NF-κB Pathway

Zhenzhen Tu,Wei Wei,Fanjun Zeng,Wenwen Wang,Yuyan Zhang,Yintao Zhang,Fusheng Zhou,Chunlin Cai,Siping Zhang,Haisheng Zhou

DOI: https://doi.org/10.1016/j.ajpath.2024.01.014

2024-02-01

Abstract:Psoriasis is a chronic inflammatory skin disease characterized by the activation of keratinocytes and the infiltration of immune cells. Overexpression of the transcription factor LIM-domain only protein 4 (LMO4) promoted by IL-23 has critical roles in regulating the proliferation and differentiation of psoriatic keratinocytes. IL-6, an autocrine cytokine in psoriatic epidermis, is a key mediator of IL-23/T helper 17-driven cutaneous inflammation. However, little is known about how IL-6 regulates the up-regulation of LMO4 expression in psoriatic lesions. In this study, human immortalized keratinocyte cells, clinical biopsy specimens, and an animal model of psoriasis induced by imiquimod cream were used to investigate the role of IL-6 in the regulation of keratinocyte proliferation and differentiation. In this study, IL-6 and LMO4 were expressed abnormally in the psoriatic epidermis. IL-6 up-regulates the expression of LMO4 and promotes keratinocyte proliferation and differentiation. Furthermore, in vitro and in vivo studies have shown that IL-6 up-regulates LMO4 expression by activating the MEK/ERK/NF-κB signaling pathway. These results suggest that IL-6 can activate the NF-κB signaling pathway, up-regulate the expression of LMO4, lead to abnormal proliferation and differentiation of keratinocytes, and promote the occurrence and development of psoriasis.

pathology
A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis.

Yihua Cai,Feng Xue,Chen Quan,Minye Qu,Na Liu,Yuan Zhang,Chris Fleming,Xiaoling Hu,Huang-Ge Zhang,Ralph Weichselbaum,Yang-Xin Fu,David Tieri,Eric C Rouchka,Jie Zheng,Jun Yan

DOI: https://doi.org/10.1016/j.jid.2018.07.025

IF: 7.59

2019-01-01

Journal of Investigative Dermatology

Abstract:IL-1 signaling pathway has been shown to play a critical role in the pathogenesis of chronic, autoinflammatory skin diseases such as psoriasis. However, the exact cellular and molecular mechanisms have not been fully understood. Here, we show that IL-1β is significantly elevated in psoriatic lesional skin and imiquimod (IMQ)-treated mouse skin. In addition, IL-1R signaling appears to correlate with psoriasis disease progression and treatment response. IL-1 signaling in both dermal γδ T cells and other cells such as keratinocytes is essential to an IMQ-induced skin inflammation. IL-1β induces dermal γδ T cell proliferation and IL-17 production in mice. In addition, IL-1β stimulates keratinocytes to secrete chemokines which preferentially chemoattract peripheral CD27 CCR6IL-17 capable producing γδ T cells (γδT17). Further studies reveal that endogenous IL-1β secretion is regulated by skin commensals to maintain dermal γδT17 homeostasis in mice. Mouse skin associated with corynebacterium, bacterial enriched in human psoriatic lesional skin has increased IL-1β and dermal γδT17 cell expansion. Thus, IL-1β-IL-1R signaling pathway may contribute to skin inflammation and psoriasis pathogenesis via the direct regulation of dermal IL-17-producing cells and stimulation of keratinocytes for amplifying inflammatory cascade.
Role of the soluble epoxide hydrolase in keratinocyte proliferation and sensitivity of skin to inflammatory stimuli

Zumer Naeem,Sven Zukunft,Arnaud Huard,Jiong Hu,Bruce D. Hammock,Andreas Weigert,Timo Frömel,Ingrid Fleming

DOI: https://doi.org/10.1016/j.biopha.2024.116127

IF: 7.419

2024-01-10

Biomedicine & Pharmacotherapy

Abstract:The lipid content of skin plays a determinant role in its barrier function with a particularly important role attributed to linoleic acid and its derivatives. Here we explored the consequences of interfering with the soluble epoxide hydrolase (sEH) on skin homeostasis. sEH; which converts fatty acid epoxides generated by cytochrome P450 enzymes to their corresponding diols, was largely restricted to the epidermis which was enriched in sEH-generated diols. Global deletion of the sEH increased levels of epoxides, including the linoleic acid-derived epoxide; 12,13-epoxyoctadecenoic acid (12,13-EpOME), and increased basal keratinocyte proliferation. sEH deletion (sEH -/- mice) resulted in thicker differentiated spinous and corneocyte layers compared to wild-type mice, a hyperkeratosis phenotype that was reproduced in wild-type mice treated with a sEH inhibitor. sEH deletion made the skin sensitive to inflammation and sEH -/- mice developed thicker imiquimod-induced psoriasis plaques than the control group and were more prone to inflammation triggered by mechanical stress with pronounced infiltration and activation of neutrophils as well as vascular leak and increased 12,13-EpOME and leukotriene (LT) B4 levels. Topical treatment of LTB4 antagonist after stripping successfully inhibited inflammation and neutrophil infiltration both in wild type and sEH -/- skin. While 12,13-EpoME had no effect on the trans-endothelial migration of neutrophils, like LTB4, it effectively induced neutrophil adhesion and activation. These observations indicate that while the increased accumulation of neutrophils in sEH-deficient skin could be attributed to the increase in LTB4 levels, both 12,13-EpOME and LTB4 contribute to neutrophil activation. Our observations identify a protective role of the sEH in the skin and should be taken into account when designing future clinical trials with sEH inhibitors.

pharmacology & pharmacy,medicine, research & experimental
IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation

Xinhui Ni,Yi Xu,Wang Wang,Baida Kong,Jian Ouyang,Jiwei Chen,Man Yan,Yawei Wu,Qi Chen,Xinxin Wang,Hongquan Li,Xiaoguang Gao,Hongquan Guo,Lian Cui,Zeyu Chen,Yuling Shi,Ronghui Zhu,Wei Li,Tieliu Shi,Lin-Fa Wang,Jinling Huang,Chen Dong,Yuping Lai

DOI: https://doi.org/10.1038/s41590-022-01339-3

2022-10-22

Pathogenesis

Abstract:Abstract Aberrant RNA splicing in keratinocytes drives inflammatory skin disorders. In the present study, we found that the RNA helicase DDX5 was downregulated in keratinocytes from the inflammatory skin lesions in patients with atopic dermatitis and psoriasis, and that mice with keratinocyte-specific deletion of Ddx5 ( Ddx5 ∆KC ) were more susceptible to cutaneous inflammation. Inhibition of DDX5 expression in keratinocytes was induced by the cytokine interleukin (IL)-17D through activation of the CD93–p38 MAPK–AKT–SMAD2/3 signaling pathway and led to pre-messenger RNA splicing events that favored the production of membrane-bound, intact IL-36 receptor (IL-36R) at the expense of soluble IL-36R (sIL-36R) and to the selective amplification of IL-36R-mediated inflammatory responses and cutaneous inflammation. Restoration of sIL-36R in Ddx5 ∆KC mice with experimental atopic dermatitis or psoriasis suppressed skin inflammation and alleviated the disease phenotypes. These findings indicate that IL-17D modulation of DDX5 expression controls inflammation in keratinocytes during inflammatory skin diseases.
Logic Programming as Hypergraph Rewriting

A. Corradini,F. Rossi,F. Parisi-Presicce

DOI: https://doi.org/10.1007/3-540-53982-4_16

1991-04-01

Abstract:
Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation

Hui Li,Qi Yao,Alberto Garcia Mariscal,Xudong Wu,Justus Hülse,Esben Pedersen,Kristian Helin,Ari Waisman,Caroline Vinkel,Simon Francis Thomsen,Alexandra Avgustinova,Salvador Aznar Benitah,Paola Lovato,Hanne Norsgaard,Mette Sidsel Mortensen,Lone Veng,Björn Rozell,Cord Brakebusch

DOI: https://doi.org/10.1038/s41467-018-03704-z

IF: 16.6

2018-04-12

Nature Communications

Abstract:The chronic skin inflammation psoriasis is crucially dependent on the IL-23/IL-17 cytokine axis. Although IL-23 is expressed by psoriatic keratinocytes and immune cells, only the immune cell-derived IL-23 is believed to be disease relevant. Here we use a genetic mouse model to show that keratinocyte-produced IL-23 is sufficient to cause a chronic skin inflammation with an IL-17 profile. Furthermore, we reveal a cell-autonomous nuclear function for the actin polymerizing molecule N-WASP, which controls IL-23 expression in keratinocytes by regulating the degradation of the histone methyltransferases G9a and GLP, and H3K9 dimethylation of the IL-23 promoter. This mechanism mediates the induction of IL-23 by TNF, a known inducer of IL-23 in psoriasis. Finally, in keratinocytes of psoriatic lesions a decrease in H3K9 dimethylation correlates with increased IL-23 expression, suggesting relevance for disease. Taken together, our data describe a molecular pathway where epigenetic regulation of keratinocytes can contribute to chronic skin inflammation.

multidisciplinary sciences
Interleukin‐17A suppresses granular layer formation in a 3‐D human epidermis model through regulation of terminal differentiation genes

Emi Sato,Narumi Yano,Yuka Fujita,Shinichi Imafuku

DOI: https://doi.org/10.1111/1346-8138.15250

IF: 3.468

2020-04-01

The Journal of Dermatology

Abstract:Immunotherapies targeting interleukin (IL)‐17 greatly improve plaque psoriasis. Most previous studies on IL‐17 focused on the T‐helper (Th)17 immune response, but investigation of the effects of IL‐17A on psoriatic epidermal structure are limited. Using an in vitro 3‐D human epidermis model, we investigated the effects of IL‐17A and IL‐17C on morphological changes and gene expression. IL‐17A directly suppressed the formation of the granular layer, whereas IL‐17C did not. IL‐17A significantly downregulated the gene expression of profilaggrin (FLG), which is a major component of keratohyalin granules in the granular layer. Global gene expression analysis of this 3‐D epidermis model showed that both IL‐17A and IL‐17C upregulated S100A7A and type 1 interferon‐related genes including MX1, IFI44L, XAF1 and IFIT1. However, only IL‐17A directly downregulated keratinocyte differentiation‐related and cornified envelope‐related genes including FLG, LOR, C1ORF68, LCE1E, LCE1B, KRT10, CST6 and RPTN. In conclusion, IL‐17A, a systemic inflammatory cytokine, affected keratinization in our 3‐D epidermis model. In contrast, IL‐17C, a locally produced cytokine, did not have strong effects on keratinization. Targeting IL‐17A does not only reduce inflammation but it may also directly affect epidermal differentiation in psoriasis.
IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory Responses

Shuai Shao,Lam C Tsoi,William R Swindell,Jiaoling Chen,Ranjitha Uppala,Allison C Billi,Xianying Xing,Chang Zeng,Mrinal K Sarkar,Rachael Wasikowski,Yanyun Jiang,Joseph Kirma,Jingru Sun,Olesya Plazyo,Gang Wang,Paul W Harms,John J Voorhees,Nicole L Ward,Feiyang Ma,Matteo Pellegrini,Alexander Merleev,Bethany E Perez White,Robert L Modlin,Bogi Andersen,Emanual Maverakis,Stephan Weidinger,J Michelle Kahlenberg,Johann E Gudjonsson,Lam C. Tsoi,William R. Swindell,Allison C. Billi,Mrinal K. Sarkar,Paul W. Harms,John J. Voorhees,Nicole L. Ward,Bethany E. Perez White,Robert L. Modlin,J. Michelle Kahlenberg,Johann E. Gudjonsson

DOI: https://doi.org/10.1016/j.jid.2021.03.019

IF: 7.59

2021-10-01

Journal of Investigative Dermatology

Abstract:Many inflammatory skin diseases are characterized by altered epidermal differentiation. Whether this altered differentiation promotes inflammatory responses has been unknown. Here we show that IRAK2, a member of the signaling complex downstream of IL-1/IL-36, correlates positively with disease severity in both AD and psoriasis. Inhibition of epidermal IRAK2 normalizes differentiation and inflammation in two mouse models of psoriasis- and AD-like inflammation. Specifically, we demonstrate that IRAK2 ties together pro-inflammatory and differentiation dependent responses and show that this function of IRAK2 is specific to keratinocytes and acts through the differentiation associated transcription factor ZNF750. Taken together, our findings suggest that IRAK2 has a critical role in promoting feed-forward amplification of inflammatory responses in skin through modulation of differentiation pathways and inflammatory responses.

dermatology
CircEIF5 contributes to hyperproliferation and inflammation of keratinocytes in psoriasis via p‐NFκB and p‐STAT3 signalling pathway

Cheng Chen,Zhenxian Yang,Xiran Yin,Shan Huang,Jianjun Yan,Qing Sun

DOI: https://doi.org/10.1111/exd.14565

2022-03-18

Experimental Dermatology

Abstract:Experimental Dermatology, Accepted Article.

dermatology
SERPINB4 Promotes Keratinocyte Inflammation via p38MAPK Signaling Pathway

Yanan Zhang,Luling Wang,Xiaoying Sun,Fulun Li

DOI: https://doi.org/10.1155/2023/3397940

IF: 4.4929

2023-03-24

Journal of Immunology Research

Abstract:Psoriasis is a chronic inflammatory skin disease characterized by infiltration of inflammatory cells and excessive proliferation of epidermal keratinocytes. SERPINB4, as a serine protease inhibitor, has been clearly expressed in the skin lesions and serum of patients with psoriasis, but the specific mechanism of action is not yet clear. Here, we showed that SERPINB4 expression was increased in skin lesions from the imiquimod (IMQ)-treated mice and M5-(a mixture of five proinflammatory cytokines: IL-17A, IL-22, IL-1α, oncostatin M, and TNF-α) treated human immortalized keratinocyte (HaCaT). Knockdown of SERPINB4 by short hairpin RNA attenuated the M5-induced keratinocyte inflammation. Conversely, lentiviral expression of SERPINB4 promoted keratinocyte inflammation. Finally, we observed that SERPINB4 stimulation activated the p38MAPK signaling pathway. Taken together, these results suggest that SERPINB4 has a critical role in psoriasis pathogenesis.

immunology
EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation

Tongmei Zhang,Luting Yang,Yao Ke,Jie Lei,Shengxian Shen,Shuai Shao,Chen Zhang,Zhenlai Zhu,Erle Dang,Gang Wang

DOI: https://doi.org/10.1038/s41419-020-03028-1

2020-10-01

Cell Death and Disease

Abstract:Abstract Psoriasis is characterized by keratinocyte hyperproliferation. While significant progress has been made in understanding the molecular mechanism regulating the proliferation of keratinocytes, little is known about the epigenetic factors that control this process. EZH2 and EZH2 mediated trimethylation of histone H3 lysine 27 (H3K27me3) was previously shown ectopically expressed in carcinoma and mediated proliferation, thereby we sought to clarify the role of EZH2–H3K27me3 in the proliferation of psoriatic keratinocyte. Interestingly, we found that EZH2 and H3K27me3 were both overexpressed in the epidermis of psoriatic lesional skin compared to normal skin. In vitro, the expression of EZH2 and H3K27me3 was stimulated in human keratinocytes treated with mixture of psoriasis-related cytokines pool (TNF-α, IFN-γ, IL-17A, and IL-22). Knockdown of EZH2 significantly reduced keratinocyte proliferative activity. Results from mRNA microarray analysis suggested that Kallikrein-8 (KLK8) might be the target gene of EZH2 in psoriatic keratinocytes. Overexpression or knockdown KLK8 could partially reverse the abnormal proliferation of keratinocytes caused by knockdown or overexpression of EZH2. In vivo, the inhibitor of EZH2, GSK126 could ameliorate the imiquimod-induced psoriasiform lesion. These results suggest that EZH2 might be a therapeutic target for the treatment of psoriasis.

cell biology

A disassemblable microstrainer for biological specimens.

Differential Regulation of Integrin Alpha 5 and Beta 4 in Normal and Psoriatic Epidermal Keratinocytes

Analysis of Epithelial–mesenchymal Transition Markers in Psoriatic Epidermal Keratinocytes

An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.

IL-17C Amplifies Epithelial Inflammation in Human Psoriasis and Atopic Eczema

Regulation of Involucrin in Psoriatic Epidermal Keratinocytes: The Roles of ERK1/2 and GSK-3β

UBE2L3 Reduces TRIM21 Expression and IL-1β Secretion in Epidermal Keratinocytes and Improves Psoriasis-Like Skin

Epigenetic Regulation of IL-23 by E3 Ligase FBXW7 in Dendritic Cells is Critical for Psoriasis-like Inflammation.

Glycyrrhizin improves the pathogenesis of psoriasis partially through IL-17A and the SIRT1-STAT3 axis

Epidermal SIRT1 regulates inflammation, cell migration, and wound healing

IL-6 Up-Regulates Expression of LIM-Domain Only Protein 4 in Psoriatic Keratinocytes through Activation of the MEK/ERK/NF-κB Pathway

A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis.

Role of the soluble epoxide hydrolase in keratinocyte proliferation and sensitivity of skin to inflammatory stimuli

IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation

Logic Programming as Hypergraph Rewriting

Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation

Interleukin‐17A suppresses granular layer formation in a 3‐D human epidermis model through regulation of terminal differentiation genes

IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory Responses

CircEIF5 contributes to hyperproliferation and inflammation of keratinocytes in psoriasis via p‐NFκB and p‐STAT3 signalling pathway

SERPINB4 Promotes Keratinocyte Inflammation via p38MAPK Signaling Pathway

EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation